fbpx
Couleur
C C C C C
Texte
T T
Skip To Content

Media

FDA Rules Against For-Profit Stem Cell Company

Quick on the heels of last week’s Washington Post article discussing the dangers of stem cell therapy, a U.S. federal judge ruled in favour of the Food and Drug Administration (FDA) in…

Read More
Microphone in front of computer screen
Podcast: Dr. Mary Sunderland in Conversation with Danielle McLaughlin

Dr. Mary Sunderland, Director of Research and Education at Fighting Blindness Canada, recently sat down with civil liberties advocate Danielle McLaughlin on the Kelly & Company Podcast to discuss the dangers of…

Read More
View of downtown Vancouver from the top of the Blue Horizon Hotel in Vancouver. You can see the mountains in the background as well as the ocean.
From Bench to Bedside and Back Again: ARVO Comes to Canada

The phrase “from the bench to the bedside” is often used to describe the path to new medical treatments, beginning with a discovery at the laboratory “bench” and finishing when patients can…

Read More
Collage of photos
From Foundation to Fighter

A Message from the President and CEO For 45 years, the Foundation Fighting Blindness has raised and directed critical funding into sight-saving research for blinding eye diseases. From our earliest days as…

Read More
Video Camera
« Gene Therapy Has Arrived! »

Canada’s first ocular gene therapy clinical trial was led by Dr. Ian MacDonald. The FBC was proud to be one of the funders who made this trial possible – as Dr. MacDonald…

Read More
Microphone
Listen to Dr. Chad Andrews on CAT’s Assistive Technologies Podcast, Banter

Our Senior Manager of Research and Education, Dr. Chad Andrews, recently appeared on Banter, a podcast run by Canadian Assistive Technologies. Beginning at 26:30, he discusses the state of FBC-funded stem cell…

Read More

Unissons nos forces

Découvrez comment votre soutien peut contribuer à tracer un avenir sans cécité! Soyez informé en exclusivité des dernières percées de la recherche en santé de la vision et des événements dans votre région en vous abonnant à notre infolettre.